{
    "title": "South African regulator approves Sinopharm COVID vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10484297/S-Africas-health-regulator-registers-Sinopharm-COVID-vaccine.html",
    "date": "2022-02-07",
    "keywords": [
        "vaccine",
        "health",
        "sinopharm",
        "government",
        "covid19",
        "sahpra",
        "pfizer",
        "regulator",
        "monday",
        "africa",
        "johnson",
        "jampj",
        "vaccination",
        "safety",
        "efficacy",
        "emergency",
        "use",
        "shot",
        "biotech",
        "johannesburg",
        "official",
        "country",
        "worsthit",
        "pandemic",
        "pfizerbiontech",
        "amp",
        "campaign",
        "year",
        "oversupply",
        "hesitancy",
        "statement",
        "approval",
        "quality",
        "mc",
        "pharma",
        "company",
        "line",
        "programme",
        "stock",
        "department",
        "authorisation",
        "world",
        "organization",
        "trial",
        "disease",
        "december",
        "manufacturer",
        "sinovac",
        "bharat",
        "booster",
        "dose",
        "immunity",
        "sarscov2",
        "virus",
        "inactivate",
        "heat",
        "radiation",
        "south",
        "adult",
        "population",
        "russias",
        "v",
        "sputnik",
        "supply",
        "vaccinedistribution",
        "scheme",
        "covax",
        "reporting",
        "promit",
        "mukherjee",
        "alexander",
        "winning",
        "edmund",
        "blair",
        "donovan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}